Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients-Reference-Cited by-同舟云学术

Polymorphisms in mTOR and Calcineurin Signaling Pathways Are Associated With Long-Term Clinical Outcomes in Kidney Transplant Recipients

Published:2018-11-14 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Campos-Salazar Antony Brayan,Genvigir Fabiana Dalla Vecchia,Felipe Claudia Rosso,Tedesco-Silva Helio,Medina-Pestana José,Monteiro Gabriela Vieira,Basso Rodrigo de Gouveia,Cerda Alvaro,Hirata Mario Hiroyuki,Hirata Rosario Dominguez Crespo

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference45 articles.

1. Assessing the impact of FoxP3 and Vav1 gene polymorphisms on kidney allograft survival.;Adamek;HLA,2017

2. Haploview: analysis and visualization of LD and haplotype maps.;Barrett;Bioinformatics,2005

3. Drug target molecules to guide immunosuppression.;Bergan;Clin. Biochem.,2016

4. Regulation and function of mTOR signalling in T cell fate decisions.;Chi;Nat. Rev. Immunol.,2012

5. Long-term follow-up of de novo use of mTOR and calcineurin inhibitors after kidney transplantation.;de Paula;Ther. Drug Monit.,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review;Pharmacogenomics;2024-04-12

2. Proteome-wide Mendelian randomization reveals the causal effects of immune-related plasma proteins on psychiatric disorders;Human Genetics;2023-04-21

3. Influencia del polimorfismo de CYP3A4 y CYP3A5 en la farmacocinética de tacrolimus en receptores de trasplante renal. Revisión narrativa;Ciencia, Tecnología y Salud;2021-12-12

4. Haematological disorders following kidney transplantation;Nephrology Dialysis Transplantation;2020-11-05

5. Differentially expressed urinary exo-miRs and clinical outcomes in kidney recipients on short-term tacrolimus therapy: a pilot study;Epigenomics;2020-11